Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Global COVID-19 Diagnostic Demand Outlook, 2020-2021 Q4 by Country, Assay Volume Quarterly - Updated to Include Q1 & Q2 2020 Actuals Data - ResearchAndMarkets.com


The "COVID-19 Global Diagnostic Demand Outlook by Country, Assay Volume Quarterly Outlook to December 2021 Separately for Molecular and Serology - Updated to Include Q1 & Q2 2020 Actuals Data" report has been added to ResearchAndMarkets.com's offering.

Can diagnostics stop an epidemic? Rapid diagnostics is key to epidemic management. But the demand is staggering. Will it stagger the diagnostics industry?

This report looks at the assay volume demands by country looking out 6 quarters to the end of 2021. The publisher looks at 3 scenarios for pandemic progression and explores diagnostics demand in each scenario. A breakout of Molecular and Serology is also included. As always, the publisher's analysts are available to breakout separate numbers to meet your needs and work with your assumptions.

The report forecasts are based on the WHO Health Security Index with specific assumptions about the effectiveness of distancing measures and the impact of health system overload on different countries. These create varying timelines of demand.

Key Topics Covered:

COVID-19. Strategic Situation Analysis

1. Introduction and Market Definition

1.1 What are Pandemics?

1.2 The Role of Zoonosis

1.3 Market Definition

1.3.1 Assay Volumes

1.3.2 Healthcare Systems Demand

1.3.3 Molecular & Serology

1.4 Methodology

1.4.1 Authors

1.4.2 Sources

1.5 Historical Perspective on Pandemics

1.5.1 HIV/AIDS PANDEMIC 2005-2012

1.5.2 FLU PANDEMIC 1968

1.5.3 ASIAN FLU 1956-1958

1.5.4 SPANISH FLU 1918

1.5.5 SIXTH CHOLERA PANDEMIC 1910-1911

1.5.6 FLU PANDEMIC 1889-1890

1.5.7 THE BLACK DEATH 1346-1353

2. The Pandemic Overview

2.1 What is a Virus?

2.1.1 Is a Virus Alive?

2.1.2 Viral Structure

2.1.3 The Viral Genome

2.1.4 Viral Mutation

2.2 The Coronavirus

2.2.1 Severe acute respiratory syndrome (SARS)

2.2.2 Middle East respiratory syndrome (MERS)

2.2.3 COVID-19. The SARS CoV 2 Virus

2.2.3.1 Signs and symptoms

2.2.3.2 Transmission

2.2.3.3 Diagnosis

2.2.3.4 Prevention

2.2.3.5 Management

2.2.3.6 Prognosis

2.2.3.7 A Note on Global Statistics Reporting

2.3 Pandemic Diagnostics

2.3.1 Risk Management - Spark and Spread

2.3.2 Dx Technology - Nucleic Acid-Based

2.3.3 Dx Technology - Immunoassay

2.3.4 Time to Market and Preparedness Issues

2.3.5 Saliva Direct Test

2.3.5.1 Research Abstract

2.3.5.2 FDA Statement on Saliva Direct Test

2.3.5.3 Impact of Saliva Direct on Forecasts and Cannibalization

3. Infection/Hospitalization Projections by Country by Quarter. All Case Scenarios

3.1 Scenarios Overview

3.1.1 WHO Global Health Security Index

3.1.2 Pandemic Progression Outlook Methodology

3.2 Scenario 1. Best Case

3.3 Scenario 2. Expected Case

3.4 Scenario 3. Worst Case

4. Diagnostic Company Profiles

6. Healthcare Systems Dx Demand Outlook

6.1 Healthcare System Demand by Country - Best Case

6.2 Healthcare System Demand by Country - Expected Case

6.3 Healthcare System Demand by Country - Worst Case

7. Molecular/Serology Dx Demand Outlook

7.1 Molecular/Serology Demand by Country - Best Case

7.2 Molecular/Serology Demand by Country - Expected Case

7.3 Molecular/Serology Demand by Country - Worst Case

For more information about this report visit https://www.researchandmarkets.com/r/ljzruc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

at 08:53
Voiant and Thirona announce commercial partnership for full scope services in imaging-based clinical trials for pulmonary diseases
Voiant (USA) and Thirona (The Netherlands) are pleased to announce they have entered a global commercial partnership, combining Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's expertise in...

at 08:51
GenEmbryomics and Progenesis Announce Strategic Partnership to Transform IVF Testing
In a move that is set to transform clinical reproductive medicine, GenEmbryomics Limited, a pioneering provider of advanced genetic testing services for embryos, and Progenesis Inc, a leading provider of preimplantation genetic testing for in vitro...

at 08:48
VIN Foundation Receives Platinum Seal of Transparency from Candid for Eighth Year in a Row
For the eighth year in a row, the VIN Foundation, a 501(c)(3) nonprofit, has earned the Platinum Seal of Transparency from Candid. This highest level of recognition from Candid, the world's largest source of information on nonprofit organizations,...

at 08:46
Autism Digest Celebrates Milestones, Innovations and a Free Issue
Autism Digest, a cornerstone in the autism community, is thrilled to announce a series of celebratory initiatives as part of its significant 25th anniversary milestone. As a leader in providing insightful content for those affected by autism, Autism...

at 08:46
Midi Health, the Fastest-Growing Virtual Clinic for Perimenopause and Menopause, Raises an Additional $60M in Series B Round - $100M Total Funding to Date - to Transform Women's Healthcare
Midi Health, the fastest-growing virtual care clinic for women navigating perimenopause and menopause, today announced the close of a $60M Series B funding round led by Emerson Collective, bringing the company's total funding raised to date to $100M....

at 08:44
Hire Health Poised to Solve the Healthcare Sector's Biggest Pain Points
Hire Health, a healthcare-focused human capital solutions firm, announced its official launch today. With a passion for improving patient care and commitment to optimal business outcomes, Hire Health is uniquely positioned to assist healthcare and...

More news about Health...


News published on and distributed by: